Mesa Laboratories
MLAB
163 hedge funds and large institutions have $681M invested in Mesa Laboratories in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 63 reducing their positions, and 30 closing their positions.
2.15% less ownership
Funds ownership: 93.15% → 91% (-2.2%)
7% less funds holding
Funds holding: 175 → 163 (-12)
11% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 63
32% less capital invested
Capital invested by funds: $1B → $681M (-$320M)
40% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 30
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$19.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.23M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.61M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.08M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$8.19M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.83M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$5.51M |
| 4 |
RA
Royce & Associates
New York
|
-$4.8M |
| 5 |
BlackRock
New York
|
-$3.86M |
MLAB Hedge Fund Activity: Q3 2022 in Review
163 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q3 2022, worth a combined $681M — down 32% from $1B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of MLAB and 18 opened new positions — a net loss of 12 holders — while 63 trimmed existing stakes and 56 added.
The largest buyer was Geneva Capital Management, opening a new position worth an estimated $19.1M. The largest seller was Invesco, cutting an estimated $8.19M.
- 163 institutional investors held Mesa Laboratories (MLAB) as of Q3 2022, down from 175 in Q2 2022.
- Funds reported $681M of Mesa Laboratories stock for Q3 2022, down 32% quarter-over-quarter.
- 18 funds opened new Mesa Laboratories positions in Q3 2022 and 30 closed out, a net change of -12 holders.
- The largest Mesa Laboratories buyer in Q3 2022 was Geneva Capital Management, an estimated $19.1M added.
- The largest Mesa Laboratories seller in Q3 2022 was Invesco, an estimated $8.19M sold.
Based on aggregated 13F filings for Q3 2022.